GeneInsight To Present Session On Molecular And Genetics Labs At Precision Medicine World Conference

Wednesday, May 24, 2017 Genetics & Stem Cells News
Email Print This Page Comment
Font : A-A+

Session Will Focus on IT Solutions for Genetics Labs

TUCSON, Ariz., May 23, 2017 /PRNewswire/ -- GeneInsight, a Sunquest Company, is presenting an educational session at

the Precision Medicine World Conference at Duke University, May 24-25, 2017, in Durham, NC. The Precision Medicine World Conference is one of the leading annual forums for precision medicine for experts across healthcare and biotechnology.  GeneInsight and MedCompGx experts will offer an in-depth look into IT solutions supporting molecular and genetics testing lab workflows and provide solutions to various challenges that arise in these labs.

In line with the conference's goal to advance precision medicine initiatives, GeneInsight and MedCompGx will present "IT Solutions in Support of Molecular and Genetics Labs" on Wednesday, May 24th at 11:00 a.m ET, in the RJR Auditorium. Presenters Chris Callahan, vice president of GeneInsight, and Paul Lang, MLS (ASCP) MD, Ph.D., technical supervisor at MedCompGx, will offer insights into bringing molecular and genetic testing to the clinical mainstream through a streamlined and scalable IT platform. This course will emphasize the benefits of platforms that can handle highly complex workflows and large data sets in an efficient, predictable manner, ultimately helping physicians provide safer, more accurate treatment for patients.

"We are thrilled to be a part of the 2017 Precision Medicine World Conference," said Chris Callahan. "As precision medicine continues to take hold within the lab, it is important for healthcare organizations to understand the best possible solutions for their lab and how these solutions can address, and dissolve, current challenges. A strong, innovative molecular genetics solution can deliver on the promise of personalized medicine that all patients deserve."

In addition to presenting, GeneInsight will be at booth #16 in the exhibitor hall. Conference attendees can view GeneInsight's molecular informatics solution, learn more about how MedCompGx implemented GeneInsight into their lab and hear more about the benefits of bringing a molecular genetics solution into their own labs.

About GeneInsight

GeneInsight, a Sunquest company, provides a molecular informatics solution that streamlines the analysis, interpretation and reporting of complex genetic tests.  In constant clinical use since 2005, GeneInsight facilitates delivery of test results to treating clinicians so they can integrate genetics into their routine diagnostic workflows.  The hosted solution includes filtration, annotation and storage tools, along with novel variant assessment, variant knowledge management and reporting capabilities. GeneInsight is a wholly owned subsidiary of Sunquest Information Systems, a pioneer in laboratory informatics.

About Sunquest Information Systems

Sunquest Information Systems Inc. provides diagnostic informatics solutions to more than 1,700 laboratories. Since 1979, Sunquest has helped laboratories and healthcare organizations across the world enhance efficiency, improve patient care, and optimize financial results. Sunquest's solutions enable world-class lab capabilities, including multi-site, multi-disciplinary support for complex anatomic, molecular and genetic testing, and engagement with physicians and patients outside the hospitals at the point of care.

Headquartered in Tucson, AZ with offices in Boston, London, Dubai, United Arab Emirates, and Bangalore, India, Sunquest is a global leader in healthcare information technology.

Contact: Stephanie Clohessy, 520-570-2599, stephanie.clohessy@sunquestinfo.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/geneinsight-to-present-session-on-molecular-and-genetics-labs-at-precision-medicine-world-conference-300462804.html

SOURCE Sunquest Information Systems, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook